Document is current
Any future updates will be listed below
-
Authors
Li, Xiang
Duan, Lijun
Mu, Shengnan
Dong, Xin
Lu, Xiaoqian
Cao, Dianbo
-
Funding
Funding for this research was provided by:
Predicting pathologic response for those resectable stage III non-small cell lung cancer patients with neoadjuvant therapy through artifcial intelligence method (JLSWSRCZX2021-054, JLSWSRCZX2021-054, JLSWSRCZX2021-054, JLSWSRCZX2021-054, JLSWSRCZX2021-054, JLSWSRCZX2021-054)
Classification and prediction for pulmonary nodules through AI-based analysis of CT images (JLSDRC2023C039-2, JLSDRC2023C039-2, JLSDRC2023C039-2, JLSDRC2023C039-2, JLSDRC2023C039-2, JLSDRC2023C039-2)
- License Information
-
More Information
Article History
Received: 30 August 2023
Accepted: 14 June 2024
First Online: 21 June 2024
Declarations
:
: The study was approved by the Medical Ethics Committee of the First Hospital of Jilin University.
: The study was informed written consent was obtained from the patient for publication of this case report and accompanying images.
: The authors declare no competing interests.
